The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) In Vitro Diagnostic medical devices (IVDs) (3)
- (-) Weight loss products (2)
- Medicine safety (43)
- Prescription medicines (40)
- COVID-19 (30)
- COVID-19 vaccines (28)
- Advertising (26)
- Regulatory compliance (26)
- Therapeutic goods regulation (23)
- Safety (17)
- Listed medicines (13)
- Non-prescription medicines (13)
- Complementary medicines (12)
- Legislation (11)
- Manufacturing (10)
- Over the counter (OTC) medicines (9)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Scheduling (national classification system) (7)
- Vaping hub (7)
- Compliance and enforcement hub (6)
- Import and export (6)
- Labelling and packaging (5)
- Medical devices safety (5)
- Medicinal cannabis hub (5)
- Shortages (5)
- Alert/Advisory (3)
- Assessed listed medicines (2)
- Cosmetics (2)
- Advisory bodies and committees (1)
- Sunscreens (1)
Search
5 result(s) found, displaying 1 to 5
-
NewsTo help sponsors and manufacturers transition to new manufacturer evidence.
-
NewsTransition period for accepting ISO 13485 ends 26 May 2023.
-
NewsThe TGA will recognise the extended transition for the European Union Medical Device Regulation (EU MDR).
-
Media releasesThe TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.
-
NewsSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.